News Quantified


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

CorMedix Therapeutics to Host In-Person and Virtual Analyst Day in New York on February 10, 2026 [Yahoo! Finance]

CorMedix Therapeutics to Host In-Person and Virtual Analyst Day in New York on February 10, 2026

CorMedix (NASDAQ:CRMD) had its price target lowered by analysts at HC Wainwright from $18.00 to $13.00. They now have a "buy" rating on the stock.

CorMedix (NASDAQ:CRMD) was given a new $13.00 price target on by analysts at Royal Bank Of Canada.

CorMedix vs. Mirum Pharma: Which Rare-Disease Stock is the Better Buy? [Yahoo! Finance]

11/12/2025

07:30 am

crmd

-1.0%

BEAT

5/6/2025

07:30 am

crmd

20.6%

BEAT

3/25/2025

07:30 am

crmd

-35.8%

BEAT

Form 4 CorMedix Inc. For: Jan 23 Filed by: Hurlburt Elizabeth

Form 4 CorMedix Inc. For: Jan 23 Filed by: Blum Susan

Form 4 CorMedix Inc. For: Jan 23 Filed by: Zelnick Kaufman Beth

Form 4 CorMedix Inc. For: Jan 26 Filed by: Stewart Robert A

Form 4 CorMedix Inc. For: Jan 26 Filed by: Lefkowitz Steven W

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}